View in EDS

Correction: Efficacy of afatinib, an irreversible ErbB family blocker, in the treatment of intracerebral metastases of non-small cell lung cancer in mice.

Saved in:
Bibliographic Details
Title: Correction: Efficacy of afatinib, an irreversible ErbB family blocker, in the treatment of intracerebral metastases of non-small cell lung cancer in mice.
Authors: Zhang SR; Hangzhou Translational Medicine Research Center, Hangzhou First People's Hospital, Nanjing Medical University, Hangzhou, 310006, China.; Hangzhou Translational Medicine Research Center, Affiliated Hangzhou First People's Hospital of Zhejiang Chinese Medical University, Hangzhou, 310006, China., Zhu LC; Hangzhou Translational Medicine Research Center, Hangzhou First People's Hospital, Nanjing Medical University, Hangzhou, 310006, China.; Department of Oncology, Hangzhou Cancer Hospital, Hangzhou, 310006, China., Jiang YP; Hangzhou Translational Medicine Research Center, Hangzhou First People's Hospital, Nanjing Medical University, Hangzhou, 310006, China., Zhang J; Hangzhou Translational Medicine Research Center, Hangzhou First People's Hospital, Nanjing Medical University, Hangzhou, 310006, China., Xu RJ; Department of Pathology, Hangzhou First People's Hospital, Nanjing Medical University, Hangzhou, 310006, China., Xu YS; Hangzhou Translational Medicine Research Center, Hangzhou First People's Hospital, Nanjing Medical University, Hangzhou, 310006, China.; Hangzhou Translational Medicine Research Center, Affiliated Hangzhou First People's Hospital of Zhejiang Chinese Medical University, Hangzhou, 310006, China., Xia B; Department of Oncology, Hangzhou Cancer Hospital, Hangzhou, 310006, China. xb0918@hotmail.com., Ma SL; Hangzhou Translational Medicine Research Center, Hangzhou First People's Hospital, Nanjing Medical University, Hangzhou, 310006, China. mashenglin@medmail.com.cn.; Hangzhou Translational Medicine Research Center, Affiliated Hangzhou First People's Hospital of Zhejiang Chinese Medical University, Hangzhou, 310006, China. mashenglin@medmail.com.cn.; Department of Oncology, Hangzhou First People's Hospital, Nanjing Medical University, Hangzhou, 310006, China. mashenglin@medmail.com.cn.
Source: Acta pharmacologica Sinica [Acta Pharmacol Sin] 2025 Aug; Vol. 46 (8), pp. 2336.
Publication Type: Published Erratum
Journal Info: Publisher: Nature Publishing Group Country of Publication: United States NLM ID: 100956087 Publication Model: Print Cited Medium: Internet ISSN: 1745-7254 (Electronic) Linking ISSN: 16714083 NLM ISO Abbreviation: Acta Pharmacol Sin Subsets: MEDLINE; PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40205010
AccessLevel: 2
PubTypeId: unknown
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Correction: Efficacy of afatinib, an irreversible ErbB family blocker, in the treatment of intracerebral metastases of non-small cell lung cancer in mice.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Zhang+SR%22">Zhang SR</searchLink>; Hangzhou Translational Medicine Research Center, Hangzhou First People's Hospital, Nanjing Medical University, Hangzhou, 310006, China.; Hangzhou Translational Medicine Research Center, Affiliated Hangzhou First People's Hospital of Zhejiang Chinese Medical University, Hangzhou, 310006, China.<br /><searchLink fieldCode="AU" term="%22Zhu+LC%22">Zhu LC</searchLink>; Hangzhou Translational Medicine Research Center, Hangzhou First People's Hospital, Nanjing Medical University, Hangzhou, 310006, China.; Department of Oncology, Hangzhou Cancer Hospital, Hangzhou, 310006, China.<br /><searchLink fieldCode="AU" term="%22Jiang+YP%22">Jiang YP</searchLink>; Hangzhou Translational Medicine Research Center, Hangzhou First People's Hospital, Nanjing Medical University, Hangzhou, 310006, China.<br /><searchLink fieldCode="AU" term="%22Zhang+J%22">Zhang J</searchLink>; Hangzhou Translational Medicine Research Center, Hangzhou First People's Hospital, Nanjing Medical University, Hangzhou, 310006, China.<br /><searchLink fieldCode="AU" term="%22Xu+RJ%22">Xu RJ</searchLink>; Department of Pathology, Hangzhou First People's Hospital, Nanjing Medical University, Hangzhou, 310006, China.<br /><searchLink fieldCode="AU" term="%22Xu+YS%22">Xu YS</searchLink>; Hangzhou Translational Medicine Research Center, Hangzhou First People's Hospital, Nanjing Medical University, Hangzhou, 310006, China.; Hangzhou Translational Medicine Research Center, Affiliated Hangzhou First People's Hospital of Zhejiang Chinese Medical University, Hangzhou, 310006, China.<br /><searchLink fieldCode="AU" term="%22Xia+B%22">Xia B</searchLink>; Department of Oncology, Hangzhou Cancer Hospital, Hangzhou, 310006, China. xb0918@hotmail.com.<br /><searchLink fieldCode="AU" term="%22Ma+SL%22">Ma SL</searchLink>; Hangzhou Translational Medicine Research Center, Hangzhou First People's Hospital, Nanjing Medical University, Hangzhou, 310006, China. mashenglin@medmail.com.cn.; Hangzhou Translational Medicine Research Center, Affiliated Hangzhou First People's Hospital of Zhejiang Chinese Medical University, Hangzhou, 310006, China. mashenglin@medmail.com.cn.; Department of Oncology, Hangzhou First People's Hospital, Nanjing Medical University, Hangzhou, 310006, China. mashenglin@medmail.com.cn.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22100956087%22">Acta pharmacologica Sinica</searchLink> [Acta Pharmacol Sin] 2025 Aug; Vol. 46 (8), pp. 2336.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Published Erratum
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Publishing+Group%22">Nature Publishing Group </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>100956087 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1745-7254 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216714083%22">16714083 </searchLink><i>NLM ISO Abbreviation: </i>Acta Pharmacol Sin <i>Subsets: </i>MEDLINE; PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40205010
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41401-025-01542-6
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 2336
    Titles:
      – TitleFull: Correction: Efficacy of afatinib, an irreversible ErbB family blocker, in the treatment of intracerebral metastases of non-small cell lung cancer in mice.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Zhang SR
      – PersonEntity:
          Name:
            NameFull: Zhu LC
      – PersonEntity:
          Name:
            NameFull: Jiang YP
      – PersonEntity:
          Name:
            NameFull: Zhang J
      – PersonEntity:
          Name:
            NameFull: Xu RJ
      – PersonEntity:
          Name:
            NameFull: Xu YS
      – PersonEntity:
          Name:
            NameFull: Xia B
      – PersonEntity:
          Name:
            NameFull: Ma SL
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 08
              Text: 2025 Aug
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1745-7254
          Numbering:
            – Type: volume
              Value: 46
            – Type: issue
              Value: 8
          Titles:
            – TitleFull: Acta pharmacologica Sinica
              Type: main
ResultId 1